Effectiveness and safety of risankizumab dose optimization in adult patients with plaque psoriasis: An international multicentre retrospective cohort study
Ahmed Bagit(Brock University), Jensen Yeung(Sunnybrook Health Science Centre), Edward Wang(University of British Columbia), Hiba Zaaroura(University of Toronto), Vimal H. Prajapati(University of Calgary), Ana Maria Lé(Centro de Genética Clínica), Asfandyar Mufti(University of Toronto), Tiago Torres(Universidade do Porto), Mark Mansour(University of Toronto), Yuliya Lytvyn(University Health Network), Jorge-Ryan Georgakopoulos(University of Toronto), Brian D. Rankin(University of Calgary), Ronald Vender(Dermatrials Research), Young Joo Park(Sutro Biopharma (United States)), Khalad Maliyar(University of Toronto)
Cited by 2
Related Papers
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure
|Circulation|2017|470
Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus
|American Journal of Physiology-Renal Physiology|2014|173
The New Biology of Diabetic Kidney Disease—Mechanisms and Therapeutic Implications
|Endocrine Reviews|2019|171
Characterisation of glomerular haemodynamic responses to SGLT2 inhibition in patients with type 1 diabetes and renal hyperfiltration
|Diabetologia|2014|162
Uric Acid as a Biomarker and a Therapeutic Target in Diabetes
|Canadian Journal of Diabetes|2015|138